26; 95% CI 0.07-0.90; p =0.03). Observational studies reported few side effects but included a heterogeneous population of patients concerning their diagnosis and the duration of antibiotic treatment.

Dalbavancin has comparable safety profile relative to other antibiotics and is well-tolerated.

Dalbavancin has comparable safety profile…[Read more]

26; 95% CI 0.07-0.90; p =0.03). Observational studies reported few side effects but included a heterogeneous population of patients concerning their diagnosis and the duration of antibiotic treatment.

Dalbavancin has comparable safety profile relative to other antibiotics and is well-tolerated.

Dalbavancin has comparable safety profile…[Read more]

26; 95% CI 0.07-0.90; p =0.03). Observational studies reported few side effects but included a heterogeneous population of patients concerning their diagnosis and the duration of antibiotic treatment.

Dalbavancin has comparable safety profile relative to other antibiotics and is well-tolerated.

Dalbavancin has comparable safety profile…[Read more]

26; 95% CI 0.07-0.90; p =0.03). Observational studies reported few side effects but included a heterogeneous population of patients concerning their diagnosis and the duration of antibiotic treatment.

Dalbavancin has comparable safety profile relative to other antibiotics and is well-tolerated.

Dalbavancin has comparable safety profile…[Read more]